Skip to Content

LCE 50 (Carbidopa, Entacapone and Levodopa 12.5 mg / 200 mg / 50 mg)

Pill with imprint LCE 50 is Brown, Round and has been identified as Carbidopa, Entacapone and Levodopa 12.5 mg / 200 mg / 50 mg. It is supplied by Sandoz Inc.

Carbidopa/entacapone/levodopa is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/entacapone/levodopa 12.5 mg / 200 mg / 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LCE 50

Carbidopa, Entacapone and Levodopa

Imprint:
LCE 50
Strength:
12.5 mg / 200 mg / 50 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Inc
National Drug Code (NDC):
00781-5613

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide